Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro - Concepedia

Concepedia

Publication | Open Access

Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro

DOI Full Paper Access

29

Citations

24

References

2014

Year

Lixian Wu, Ying Wu, Ruijia Chen, Yang Liu, Lisen Huang, Liguang Lou, Zhi‐Hong Zheng, Yuanzhong Chen, Jianhua Xu

Acta Pharmacologica Sinica

Hematological MalignancyMutant Bcr-ablMedicineImmunologyCurcumin Derivative C817OncologyCell BiologyCancer ResearchTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1